Zobrazeno 1 - 6
of 6
pro vyhledávání: '"L L, Rosendorf"'
Publikováno v:
Molecular biotherapy. 2(2)
Human antibody responses to immunotoxin components were evaluated in 21 melanoma patients who were treated with XomaZyme-MEL, a murine monoclonal antimelanoma antibody-ricin A chain conjugate. Twenty of the 21 melanoma patients produced antibodies ag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4c230f38354fdd18c7a78f920efa232e
https://pubmed.ncbi.nlm.nih.gov/2363853
https://pubmed.ncbi.nlm.nih.gov/2363853
Autor:
L L, Rosendorf, F H, Kayser
Publikováno v:
Pathologia et microbiologia. 41(3-4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::64b83d75c90f278eac528d3aaa72d505
https://pubmed.ncbi.nlm.nih.gov/4444824
https://pubmed.ncbi.nlm.nih.gov/4444824
Autor:
L E, Spitler, M, del Rio, A, Khentigan, N I, Wedel, N A, Brophy, L L, Miller, W S, Harkonen, L L, Rosendorf, H M, Lee, R P, Mischak
Publikováno v:
Cancer research. 47(6)
We conducted a trial of a murine monoclonal antimelanoma antibody-ricin A chain immunotoxin (XOMAZYME-MEL) in 22 patients with metastatic malignant melanoma. The dose of immunotoxin administered ranged from 0.01 mg/kg daily for 5 days to 1 mg/kg dail
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::197116ded51fcb34917fc2c4947db3cb
https://pubmed.ncbi.nlm.nih.gov/3493066
https://pubmed.ncbi.nlm.nih.gov/3493066
Publikováno v:
The Journal of thoracic and cardiovascular surgery. 67(2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f912c05d17f39c74f14d33912ca30c40
https://pubmed.ncbi.nlm.nih.gov/4204248
https://pubmed.ncbi.nlm.nih.gov/4204248
Autor:
C E Reinhold, A Khentigan, H.M. Lee, L L Rosendorf, Lynn E. Spitler, S W Corpuz, Barry L. Engelstad, M J Del Rio, John P. Huberty, E C Ramos
Publikováno v:
Radiology. 161(2)
A phase 1 study was conducted using a monoclonal antimelanoma antibody-DTPA conjugate labeled with indium-111, for immunolymphoscintigraphy in patients with metastatic melanoma. The imaging agent, labeled with 1 mCi (37 MBq) In-111, was administered
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa4bdd16029a1ac3ea58374369eb67bc
https://pubmed.ncbi.nlm.nih.gov/3763912
https://pubmed.ncbi.nlm.nih.gov/3763912
Publikováno v:
Radiology [Radiology] 1978 Jun; Vol. 127 (3), pp. 757-61.